Search results for "PROSTAGLANDIN"

showing 10 items of 232 documents

V2-receptor–mediated relaxation of human renal arteries in response to desmopressin

1999

The effects of deamino-8-D-arginine vasopressin (desmopressin), a V2 receptor antidiuretic agonist, were studied in isolated rings from branches of renal arteries obtained from 22 patients undergoing nephrectomy. The rings were suspended in organ bath chambers for isometric recording of tension. In precontracted rings with norepinephrine (10(-6) to 3 x 10(-6) mol/L), desmopressin (10(-11) to 3 x 10(-7) mol/L) caused endothelium-dependent relaxation (81%+/-4% reversal of the initial contraction in arteries with endothelium; 20%+/-4% in arteries without endothelium; P < .05). The relaxation to desmopressin in rings with endothelium was reduced significantly by indomethacin (10(-6) mol/L) and …

AdultMaleAgonistReceptors VasopressinVasopressinmedicine.medical_specialtymedicine.drug_classMuscle RelaxationIndomethacinIn Vitro TechniquesRenal AgentsMuscle Smooth VascularRenal ArteryIsometric ContractionArginine vasopressin receptor 2Internal medicineInternal MedicinemedicineHumansCyclooxygenase InhibitorsDeamino Arginine VasopressinEnzyme InhibitorsDesmopressinReceptorAgedVasopressin receptorbusiness.industryAntidiuretic Hormone Receptor AntagonistsMiddle AgedVasodilationNG-Nitroarginine Methyl EsterEndocrinologyCirculatory systemProstaglandinsFemaleNitric Oxide SynthasebusinessAntidiuretic Hormone Receptor Antagonistshormones hormone substitutes and hormone antagonistsmedicine.drugAmerican Journal of Hypertension
researchProduct

Endothelium-dependent relaxation of human saphenous veins in response to vasopressin and desmopressin

1997

Purpose: The goal of this study was to determine the effects of vasopressin and the selective V 2 -receptor agonist desmopressin on human saphenous veins, with special emphasis on endothelium-mediated responses. Methods: Human saphenous vein segments were obtained from 35 patients undergoing coronary bypass surgery. Paired segments, one normal and the other deendothelized by gentle rubbing, were mounted for isometric recording of tension in organ baths. Concentration-response curves to vasopressin and desmopressin were determined in the presence and in the absence of either the V,-receptor antagonist d(CH 2 ) 5 Tyr(Me)AVP (10 −6 mol/L), the V 1 -V 2 receptor antagonist desGly-d(CH 2 ) 5 D-T…

AdultMaleAgonistReceptors Vasopressinmedicine.medical_specialtyVasopressinVasopressinsmedicine.drug_classVasodilator AgentsIndomethacinVasodilationHormone AntagonistsVasotocinIsometric ContractionInternal medicinemedicineHumansVasoconstrictor AgentsCyclooxygenase InhibitorsDeamino Arginine VasopressinSaphenous VeinEnzyme InhibitorsDesmopressinReceptorAgedDose-Response Relationship Drugbusiness.industryAntagonistMiddle AgedReceptor antagonistArginine VasopressinNG-Nitroarginine Methyl EsterEndocrinologyProstaglandinsFemaleSurgeryEndothelium VascularNitric Oxide Synthasemedicine.symptombusinessCardiology and Cardiovascular MedicineAntidiuretic Hormone Receptor AntagonistsVasoconstrictionhormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Vascular Surgery
researchProduct

The effects of prostaglandin F2α in the human eye

1985

The ocular effects of 200 micrograms of topically applied prostaglandin F2 alpha were studied in 18 nonglaucomatous volunteers. A fall in intraocular pressure was seen in the prostaglandin-treated eyes when compared with the placebo-treated control eyes. The maximum intraocular pressure reduction was observed at the 7th h and hypotensive ocular effect persisted for 24 h. Prostaglandins did not produce any change in pupillary diameter or signs of intraocular inflammation visible by anterior segment biomicroscopy or iris fluorescein angiography. The drug caused side effects: conjunctival hyperemia was constant and many patients complained of ocular smarting and headache. It could be useful in…

AdultMaleIntraocular pressuregenetic structuresOcular hypertensionProstaglandinHyperemiaDinoprostEyePupilCellular and Molecular Neurosciencechemistry.chemical_compoundHumansMedicineIris (anatomy)VolunteerIntraocular PressureAgedmedicine.diagnostic_testbusiness.industryProstaglandins FHeadacheMiddle Agedmedicine.diseaseFluorescein angiographyeye diseasesSensory SystemsOphthalmologymedicine.anatomical_structurechemistryAnesthesiaFemaleHuman eyesense organsbusinessConjunctivaGraefe's Archive for Clinical and Experimental Ophthalmology
researchProduct

New Immunohistologic Findings on the Differential Role of Cyclooxygenase 1 and Cyclooxygenase 2 in Nasal Polyposis

2005

Background Cyclooxygenase 1 (Cox-1) plays a key role in arachidonic acid metabolism and in the pathophysiology and immunology of nasal polyposis in patients suffering from aspirin intolerance. We hypothesize that Cox-2 also might be relevant in the etiology of nasal polyps of aspirin-tolerant patients by their effects on inflammatory mediators as well as on microvascular permeability. Methods Fifty-two surgical specimens were immunohistochemically labeled for Cox-1 and Cox-2. Specimens were taken from chronically inflamed mucosa (n = 19) and from nasal polyps (n = 19) during endonasal sinus surgery. Controls were obtained from healthy nasal respiratory mucosa (n = 14), harvested during turb…

AdultMaleRespiratory MucosaEpithelium03 medical and health sciencesNasal Polyps0302 clinical medicineotorhinolaryngologic diseasesHumansMedicineIn patientNasal polyps030223 otorhinolaryngologybiologybusiness.industryMembrane ProteinsMiddle Agedmedicine.diseaseImmunohistochemistryPathophysiologyEpitheliumArachidonic acid metabolismmedicine.anatomical_structureOtorhinolaryngologyCyclooxygenase 2Prostaglandin-Endoperoxide Synthases030220 oncology & carcinogenesisImmunologyCyclooxygenase 1biology.proteinImmunohistochemistryFemaleASPIRIN INTOLERANCECyclooxygenasebusinessAmerican Journal of Rhinology
researchProduct

Comparison of the anticonstrictor action of dihydropyridines (nimodipine and nicardipine) and Mg2+ in isolated human cerebral arteries.

1992

The isometric tension recorded from ring segments of branches of human middle cerebral artery was the parameter used to study the inhibition of spasmogen-induced contractions as model for cerebral vasospasm. Concentration-response curves to 5-hydroxytryptamine (10(-9)-3 x 10(-5) M) and prostaglandin F2 alpha (10(-7)-3 x 10(-5) M) were inhibited in Ca(2+)-free medium and in Ca(2+)-free medium to which EGTA (1 mM) had been added, respectively. Nimodipine (10(-7), 10(-5) M), nicardipine (10(-7), 10(-5) M) and Mg2+ (magnesium sulfate 10(-4), 10(-2) M) inhibited the 5-HT-elicited contractions, and this inhibition was similar for the highest concentrations tested. In contrast, nimodipine and nica…

AdultMaleSerotoninNicardipineCerebral arteriesProstaglandinPharmacologyIn Vitro TechniquesDinoprostchemistry.chemical_compoundNicardipineCerebral vasospasmmedicine.arterymedicineHumansMagnesiumNimodipineAgedPharmacologyAged 80 and overChemistryCerebral ArteriesMiddle AgedEGTAIschemic Attack TransientVasoconstrictionAnesthesiaMiddle cerebral arteryCirculatory systemCalciumFemaleNimodipinemedicine.drugEuropean journal of pharmacology
researchProduct

Polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein are associated with chronic spontaneous urticaria and urinary leukotriene E4

2011

The mechanisms of chronic spontaneous urticaria (CSU) continue to be unknown. Our working hypothesis is that polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein may be involved in the pathways leading to CSU. We examined five candidate polymorphisms of cyclo-oxygenases 1 and 2 and of 5-lipo-oxygenase-activating protein in 109 controls and in 94 CSU patients from Northern Italy. We also examined the levels of urinary leukotriene E4 (LTE4) before and after challenge with ASA. A multiple regression model was found to show that COX-2 5'UTR T/G, COX-2 Exon 10 T/C, and FLAP -336 G/A polymorphisms were significantly associated with CSU, with the minor allele more represented …

AdultMaleSettore MED/09 - Medicina InternaAdolescentGenotypeUrticariaUrinary system5-Lipoxygenase-Activating ProteinsSingle-nucleotide polymorphismDermatologyYoung Adultchemistry.chemical_compoundExonchronic spontaneous urticaria hypersensivity to aspirin cyclo-oxygenases 5-lipo-oxygenase-activating protein urinary leukotriene E4GenotypeHumansMedicineAllele5-lipoxygenase-activating proteinAgedLeukotriene E4Settore MED/04 - Patologia GeneraleLeukotriene E4Polymorphism Geneticbiologybusiness.industryMiddle AgedMinor allele frequencychemistryProstaglandin-Endoperoxide SynthasesChronic DiseaseImmunologybiology.proteinFemalebusiness
researchProduct

Increased prostaglandin E2 concentrations and cyclooxygenase-2 expression in asthmatic subjects with sputum eosinophilia.

2003

Abstract Background Prostaglandin E 2 (PGE 2 ) is known to be produced within human airways, but it is not clear whether in airway diseases it can play a deleterious or a beneficial role. Recently it has been reported that PGE 2 can enhance eosinophil survival in vitro. Objective To evaluate whether the concentrations of PGE 2 in asthmatic airways correlate with the number of eosinophils and can be responsible for eosinophil-enhanced survival and to identify the cyclooxygenase isoform contributing to the synthesis of PGE 2 by cells present in asthmatic airways. Methods Reversed-phase high-performance liquid chromatography and/or specific radioimmunoassay was used to measure PGE 2 concentrat…

AdultMaleSputum Cytologymedicine.medical_treatmentImmunologyApoptosisDinoprostoneLeukocyte CountRibonucleasesEosinophiliaImmunology and AllergyMedicineHumansProstaglandin E2Eosinophil cationic proteinbiologybusiness.industryEosinophil Granule ProteinsOsmolar ConcentrationSputumMembrane ProteinsBlood ProteinsEosinophilEosinophil Granule ProteinsMiddle AgedImmunohistochemistryAsthmaEosinophilsIsoenzymesmedicine.anatomical_structureCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesImmunologybiology.proteinSputumFemaleCyclooxygenasemedicine.symptombusinessmedicine.drugProstaglandin EThe Journal of allergy and clinical immunology
researchProduct

The exposure of healthy volunteers to 200 ppm 1,1,1-trichloroethane increases the concentration of proinflammatory cytokines in nasal secretions

1999

Objectives: Irritating effects of organic solvents have usually been measured by means of questionnaires. The aim of the present study was to evaluate the sensitivity of different methods of detecting subclinical irritating effects. Methods: Twelve healthy, non-smoking students were exposed to 200 ppm and to 20 ppm 1,1,1-trichloroethane in an exposure chamber, using a crossover design. The amounts of interleukins (IL)-1β, IL-6 and IL-8 and prostaglandin E2 (PGE2) in nasal secretions were measured. Mucociliary transport time was determined with the saccharine test. Ciliary beat frequency of nasal epithelial cells was measured with video-interference contrast microscopy. Subjective symptoms w…

AdultMalemedicine.medical_specialtyMucous membrane of nosemedicine.disease_causeDinoprostoneStatistics NonparametricProinflammatory cytokineInternal medicinemedicineHumansTrichloroethanesProstaglandin E2Subclinical infectionCross-Over StudiesInhalationInterleukin-6ChemistryInterleukinsInterleukin-8Public Health Environmental and Occupational HealthCrossover studyNasal MucosaEndocrinologyMucociliary ClearanceImmunologyToxicitySolventsIrritationInterleukin-1medicine.drugInternational Archives of Occupational and Environmental Health
researchProduct

Relaxation induced by milrinone and rolipram in human penile arteries and veins

2002

Abstract We studied the relaxant effects of milrinone, an inhibitor of phosphodiesterase 3, and rolipram, an inhibitor of phosphodiesterase 4, on contracted human penile dorsal artery and deep dorsal vein. Vascular rings from 12 multi-organ donors were suspended in organ baths for isometric recording of tension. Both milrinone and rolipram inhibited (100%) the contraction induced by noradrenaline and shifted the relaxation–response curves to the cAMP forming agents prostaglandin E1 and forskolin to the left. The findings indicate that the cAMP pathway appears to be a main determinant of relaxation in human penile vessels.

AdultMalemedicine.medical_specialtyPhosphodiesterase InhibitorsPhosphodiesterase 3Penile arteryBiologyMuscle Smooth Vascularchemistry.chemical_compoundInternal medicinemedicineHumansDrug InteractionsChildProstaglandin E1RolipramPharmacologyForskolinDose-Response Relationship DrugColforsinMiddle AgedVasodilationEndocrinologymedicine.anatomical_structurechemistryCirculatory systemMilrinoneRolipramMilrinonePenisBlood vesselmedicine.drugEuropean Journal of Pharmacology
researchProduct

The Effects of Prostaglandin E-1 in Patients with Intermittent Claudication

2006

Aim of the study is to evaluate the effects of Prostaglandin E-1 (PGE-1) in patients with peripheral arterial disease (PAD) at the 2nd b stage Fontaines classification. The study, controlled, single blinded, enrolled 123 patients with intermittent claudication that were randomised in two groups; the first group received a treatment with PGE-1 while the second one received a pentoxifylline-buflomedil association by venous infusion. We evaluated: Pain Free Walking Distance (PFWD), Maximum Walking Distance (MWD), Rest Flow (RF), Peak Flow (PF), Basal (BVR) and Minimal Vascular Resistance (MVR) with a strain gauge plethysmograph, Resting Flow (RF), Peak Flow (PF), time to reach the Peak Flow (t…

AdultMalemedicine.medical_specialtyPyrrolidinesVasodilator AgentsProstaglandinHemodynamicsWalkingSeverity of Illness IndexMicrocirculationchemistry.chemical_compoundInternal medicineLaser-Doppler FlowmetrymedicineHumansPlethysmographAlprostadilPentoxifyllineInfusions IntravenousAgedPharmacologybusiness.industryHematologyGeneral MedicineIntermittent ClaudicationMiddle AgedLaser Doppler velocimetryIntermittent claudicationSurgeryPeripheralPlethysmographyDrug CombinationsTreatment Outcomemedicine.anatomical_structurechemistryRegional Blood FlowExercise TestVascular resistanceCardiologyMolecular MedicineFemaleVascular Resistancemedicine.symptomCardiology and Cardiovascular MedicinebusinessCardiovascular &amp; Hematological Disorders-Drug Targets
researchProduct